MedTrace Logo

Multi-center Clinical Study of Guli Capsules in the Treatment of Knee Osteoarthritis

NCT02484508 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 220

Last updated 2015-06-29

No results posted yet for this study

Summary

Previous study showed that Guli capsule could suppress the adjuvant multiple arthritis; have inhibitory effect on carrageenan gelatinous and formaldehyde foot swelling; improve the symptom of osteoporosis patients; and improve pain and limited joint activities of rheumatoid patients.

To further verify the clinical effect of Guli capsule in the treatment of knee osteoarthritis, the investigators perform this multi-center clinical study.

Conditions

Interventions

DRUG

Guli capsule

Guli capsule,as the experimental drug,is taken 3 grains each time, 3 time per day

DRUG

Kangguzengsheng capsule

Kangguzengsheng capsule, as the active comparator, is taken 3 grains each time, 3 time per day

Sponsors & Collaborators

  • Wangjing Hospital, China Academy of Chinese Medical Sciences

    collaborator OTHER

  • The First Affiliated Hospital of Guiyang College of Traditional Chinese Medicine

    collaborator UNKNOWN

  • People's Hospital of Anshun City of Guizhou Province

    collaborator OTHER

  • Guizhou Bailing Group Pharmaceutical Co Ltd

    lead INDUSTRY

Principal Investigators

  • Weiheng Chen, MD Dr. · ICMJE

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-03-31
Primary Completion
2016-03-31
Completion
2016-03-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02484508 on ClinicalTrials.gov